US pharma major Eli Lilly plans to bolster its domestic medicine production across therapeutic areas by building four new ...

The US Food and Drug Administration (FDA) has accepted for review Regeneron Pharmaceuticals’ resubmission of the Biologics ...

Danish dermatology specialist LEO Pharma has announced results showing a strong performance in 2024, with both sales growth ...

Positive high-level results from a planned interim analysis of the SERENA-6 Phase III trial showed that AstraZeneca’s ...

Ligand Pharmaceuticals (Nasdaq: LGND) has entered into a royalty financing agreement with Castle Creek Biosciences, providing ...

Swiss biotech company Idorsia has revised its collaboration terms with Viatris, reducing its financial commitment to the ...

California-based biotech Eikon Therapeutics today announced the initial closing of a $350.7 million Series D financing. Since ...

Shares of Sweden’s immune-oncology firm Alligator Bioscience were up almost 160% at 0.11 kronor by early afternoon today, ...

Candel Therapeutics (Nasdaq: CADL) has released final data from a Phase II trial of its investigational immunotherapy, ...

Cardiovascular diseases specialist Kiniksa Pharmaceuticals International has announced updates to its pipeline alongside ...

Israel-headquartered Teva Pharmaceutical Industries’ US subsidiary and France’s and Medincell announced that the supplemental ...